Asthma mortality and long-acting beta2-agonists in five major European countries, 1994-2004

Journal of Asthma

Volumn 46, Issue 6, 2009, Pages 546-551

  Chatenoud, Liliane ^a   Malvezzi, Matteo ^a,c   Pitrelli, Andrea ^b   La Vecchia, Carlo ^a,c   Bamfi, Francesco ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b GSK   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Asthma; Drug consumption; Joinpoint regression; Long acting beta 2 agonist; Mortality; Trends

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COCHRANE LIBRARY; DISEASE CONTROL; FEMALE; FRANCE; GERMANY; HUMAN; INHALER; ITALY; JOINPOINT REGRESSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; REGRESSION ANALYSIS; SCHOOL CHILD; SPAIN; UNITED KINGDOM;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE DISTRIBUTION; AGED; ASTHMA; CHILD; CHILD, PRESCHOOL; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; FEMALE; FRANCE; GERMANY; GREAT BRITAIN; HUMANS; ITALY; MALE; MIDDLE AGED; MORTALITY; RECEPTORS, ADRENERGIC, BETA-2; SEX DISTRIBUTION; SPAIN; YOUNG ADULT;

EID: 68849112844     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900902849889     Document Type: Article

References (41)

1. Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-1986. Br Med J 1990; 300:1306-1310.
2. Pearce N, Douwes J, Beasley R. The rise and rise of asthma: A new paradigm for the new millennium? J Epidemiol Biostat 2000; 5:5-16.
3. Soler M, Chatenoud L, Negri E, La Vecchia C. Trends in asthma mortality in Italy and Spain, 1980-1996. Eur. J. Epidemiol. 2001; 17:545-549.
4. Cadet B, Robine JM, Leibovici D. Dynamique de la mortality asthmatique en France: Fluctuations saisonnieres et crise de mortalite' en 1985-1987. Rev Epidem et Sante' Publ 1994; 42:103-118.
5. LaVecchia C, Levi F, Lucchini F. Trends in mortalita from bronchial asthma in Switzerland, 1969-1993. Rev Epidem et Sante' Publ 1996; 44:155-161.
6. Beasley R, Pearce N, Crane J, Burgess C. β-agonists: What is the evidence that their use increases the risk of asthmamorbidity andmortality? J Allergy Clin Immunol 1999; 103:S18-30.
7. Sin DD, Man J, Sharpe H, Gan WQ, Man SF. Pharmacological management to reduce exacerbations in adults with asthma. A systematic review and meta-analysis. JAMA 2004;292:367-376.
8. Speizer FE, Doll R, Heaf DP. Investigation into the use of drugs preceding death from asthma. BMJ 1968; 1:229-243.
9. Inman WH, Adelstein AM. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet 1969; 2:279-285.
10. Burney PG. Asthma mortality in England and Wales: Evidence for a further increase, 1974-1984. Lancet 1986; 2:323-326.
11. Anderson HR, Gupta R, Strachan DP, Limb ES. 50 years of asthma: UK trends from 1955 to 2004. Thorax 2007; 62:85-90.
12. Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-1983: Case-control study. Lancet 1989; 1:917-922.
13. Pearce N, Beasley R, Crane J, Burgess C, Jackson R. End of the New Zealand asthma mortality epidemic. Lancet 1995; 345:41-44.
14. Walters EH, Gibson PG, Lasserson TJ, Walters JA. Long-acting beta2- agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database of Systematic Reviews 2007, Issue 1. Art.: CD001385.
15. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthmarelated deaths. Ann Intern Med 2006; 144:904-912.
16. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129:15-26.
17. Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993; 306:1034-1037. (Pubitemid 23105961)
18. Glassroth J. The role of long-acting β2-agonists in the management of asthma: analysis, meta-analysis and more analysis. Ann Intern Med, 2006; 144:936-937. (Pubitemid 46768135)
19. European Commission, Eurostat (home Page. Available at: http://epp.eurostat.ec.europa.eu/portal/page? pageid=1090,30070682,1090 30298591& dad=portal& schema=PORTAL (accessed July 17 2006 and December 21 2006).
20. Doll R, Smith PG. Comparison between registries: age-standardized rates. In: Waterhouse JAH, Muir CS, Shanmugaratnam K, Powell J, Peacham D, Whelan S, eds. Cancer incidence in five continents. Vol.4 Lyon: IARC, 1982. IARC Scientific publication 42, 671-675
21. National Cancer Institute. Joinpoint regression Program, version 3.0, September 2006. Available at http:/ srab.cancer.gov/joinpoint.
22. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19:335-51. Erratum in 2001; 20:655.
23. La Vecchia C, Fasoli M, Negri E, Tognoni G. Fall and rise in asthma mortality in Italy, 1968-1984. Int J Epidemiol 1989; 18:998-999.
24. Mormile F, Chiappini F, Feola G, Ciappi G. Deaths from asthma in Italy (1974-1988): Is there a relationship with changing pharmacological approaches? J Clin Epidemiol 1996; 49:1459-1466.
25. Romano F, Recchia G, Staniscia T, Bonitatibus A, Villa M, Nicolosi A, De Carli G, Mannino S. Rise and fall of asthma-related mortality in Italy and sales of β2-agonists, 1980-1994. Eur J Epidemiol 2000; 16:783-787.
26. Jenkins MA, Hurley SF, Bowes G, McNeil JJ. Use of antiasthmatic drugs in Australia. Med J Aust 1990; 153:323-328.
27. Melissinos C, Gourgoulianis K, Adamidis S. Inhaled Drug Consumption and Asthma Mortality in Greece. Chest 1995; 107:1771-1772.
28. Eder W, Ege MJ, von Mutius E. The Asthma Epidemic. N Engl J Med 2006; 355:2226-2235.
29. National Institutes of Health. Global strategy for asthma management and prevention. Betesda, MD: National Institutes of Health, 2004; NIH publication 02-3659.
30. O'Byrne PM, Adelroth E. β2 D́ej̀a vu. Chest 2006; 129:3-5.
31. Rider NL, Craig TJ. A safety review of long-acting beta2-agonists in patients with asthma. J Am Osteopath Assoc 2006;106:562-567. (Pubitemid 44704015)
32. Gupta R, Anderson HR, Strachan DP, Maier W, Watson L. International trends in admissions and drug sales for asthma. Int J Tuberc Lung Dis 2006; 10:138-145. (Pubitemid 43275536)
33. Suissa S, Ernst P. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic. J Clin Epidemiol 1997; 50:1079-1088. (Pubitemid 27477984)
34. Shelley M, Croft P, Chapman S, Pantin C. Is the quality of asthma prescribing, as measured by the general practice ratio of corticosteroid to bronchodilator, associated with asthma morbidity? J Clin Epidemiol 2000;53:1217-1221.
35. Stafford RS, Ma J, Finkelstein SN, Haver K, Cockburn I. National trends in asthma visits and asthma pharmacotherapy, 1978-2002. J Allergy Clin Immunol 2003; 111:729-735.
36. Krawiec ME, Jarjour NJ. Leukotriene receptor antagonists. Semin Respir Crit Care Med 2002; 23:399-410.
37. Deykin A, Wechsler ME, Boushey HA, Chinchilli VM, Kunselman SJ, Craig TJ, DiMango E, Fahy JV, Kraft M, Leone F, Lazarus SC, Lemanske RF Jr, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Israel E. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med. 2007;175:228-234.
38. Ducharme FM, Lasserson TJ, Cates CJ. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database of Systematic Reviews 2006, Issue 4 Art.:CD003137.
39. Campbell MJ, Cogman GR, Holgate ST, Johnston SL. Age-specific trends in asthma mortality in England and Wales, 1983-1995: Results of an observational study. Br Med J 1997; 314:1439-1441.
40. Hunt LW Jr, Silverstein MD, Reed CE, O'Connell EJ, O'Fallon WM, Yunginger JW. Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA 1993; 269:1947-1952. (Pubitemid 23106866)
41. Rutstein DD, Berenberg W, Chalmers TC, Fishman AP, Perrin EB, Zuidema GD. Measuring the quality of medical care: second revision of tables of indexes. N Engl J Med 1980; 302:1146. (Pubitemid 10107535)